Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Vito Lorusso. (2016) Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron. Therapeutics and Clinical Risk Management 12, pages 917-925.
Read now
Read now
Rudolph M. Navari. (2016) The safety and efficacy of NEPA (netupitant and palonosetron) in the treatment of chemotherapy-induced nausea and vomiting. Expert Review of Quality of Life in Cancer Care 1:4, pages 263-268.
Read now
Read now
Rudolph M. Navari. (2016) The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting. Expert Opinion on Drug Safety 15:3, pages 343-356.
Read now
Read now
Rudolph M Navari. (2015) Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV). Drug Design, Development and Therapy 9, pages 155-161.
Read now
Read now
Rudolph M Navari. (2015) Rolapitant for the treatment of chemotherapy-induced nausea and vomiting. Expert Review of Anticancer Therapy 15:10, pages 1127-1133.
Read now
Read now
Articles from other publishers (11)
Ruichao Chu. (2022) Effect of Palonosetron on Physical Symptoms of Surgical Patients: A Systematic Review and Meta-Analysis. Computational and Mathematical Methods in Medicine 2022, pages 1-10.
Crossref
Crossref
Rui Chen, Hongyun Wang, Wen Zhong, Salvatore Chessari, Corinna Lanzarotti, Alberto Bernareggi & Pei Hu. (2021) Pharmacokinetics and safety evaluation of oral Palonosetron in Chinese healthy volunteers: A phase 1, open-label, randomized, cross-over study. European Journal of Pharmaceutical Sciences 160, pages 105752.
Crossref
Crossref
Nicola Di Renzo, Maurizio Musso, Rosanna Scimè, Alessandra Cupri, Tommasina Perrone, Clara De Risi, Domenico Pastore, Attilio Guarini, Andrea Mengarelli, Fabio Benedetti, Patrizio Mazza, Vera Capria, Patrizia Chiusolo, Luca Cupelli, Vincenzo Federico, Valentina Bozzoli, Anna Rita Messa, Paolo Codega, Erminio Bonizzoni & Giorgina Specchia. (2020) Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin’s lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter study. Bone Marrow Transplantation 55:11, pages 2114-2120.
Crossref
Crossref
Meinolf Karthaus, Daniel Voisin, Giada Rizzi & Tudor Ciuleanu. (2020) Phase 3 Study of Palonosetron IV Infusion Vs. IV Bolus for Chemotherapy-Induced Nausea and Vomiting Prophylaxis After Highly Emetogenic Chemotherapy. Journal of Pain and Symptom Management 60:3, pages 568-576.
Crossref
Crossref
Murat Araz, Mustafa Karaagac, Levent Korkmaz, Lokman Koral, Fatih Inci, Ismail Beypinar, Mukremin Uysal & Mehmet Artac. (2019) Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study. Cancer Chemotherapy and Pharmacology 83:6, pages 1091-1097.
Crossref
Crossref
Rudolph M. Navari. 2019. International Manual of Oncology Practice. International Manual of Oncology Practice
1007
1045
.
Qili Liu, Chengmao Zhou, Zeqing Bao & Yu Zhu. (2017) Effects of palonosetron and ondansetron on preventing nausea and vomiting after laparoscopic surgery. Journal of International Medical Research 46:1, pages 411-420.
Crossref
Crossref
Rudolph M. Navari. (2017) Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients. Pediatric Drugs 19:3, pages 213-222.
Crossref
Crossref
Shuxian Qu, Zhendong Zheng, Zhaozhe Liu, Jianing Qiu & Xiaodong Xie. (2017) The use of aprepitant and palonosetron in preventing chemotherapy-related nausea and vomiting inlung cancer patients. Oncology and Translational Medicine 3:3, pages 108-110.
Crossref
Crossref
Leigha Rowbottom, Rachel McDonald, Angela Turner, Edward Chow & Carlo DeAngelis. (2016) An Overview of Radiation-Induced Nausea and Vomiting. Journal of Medical Imaging and Radiation Sciences 47:3, pages S29-S38.
Crossref
Crossref
Ka-Rham Kim, Gaeun Kang, Myung-Seo Ki, Hyun-Jeong Shim, Jun-Eul Hwang, Woo-Kyun Bae, Ik-Joo Chung, Jong-Keun Kim, Seongwook Jeong & Sang-Hee Cho. (2015) A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting. BioMed Research International 2015, pages 1-7.
Crossref
Crossref